These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33820504)

  • 21. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
    Sahoo AK; Dandapat J; Dash UC; Kanhar S
    J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A molecular approach in drug development for Alzheimer's disease.
    Agatonovic-Kustrin S; Kettle C; Morton DW
    Biomed Pharmacother; 2018 Oct; 106():553-565. PubMed ID: 29990843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease.
    Mezeiova E; Chalupova K; Nepovimova E; Gorecki L; Prchal L; Malinak D; Kuca K; Soukup O; Korabecny J
    Curr Alzheimer Res; 2019; 16(9):772-800. PubMed ID: 30819078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dimeric Tacrine(10)-hupyridone as a Multitarget-Directed Ligand To Treat Alzheimer's Disease.
    Xuan Z; Gu X; Yan S; Xie Y; Zhou Y; Zhang H; Jin H; Hu S; Mak MSH; Zhou D; Keung Tsim KW; Carlier PR; Han Y; Cui W
    ACS Chem Neurosci; 2021 Jul; 12(13):2462-2477. PubMed ID: 34156230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets.
    Uddin MS; Al Mamun A; Kabir MT; Ashraf GM; Bin-Jumah MN; Abdel-Daim MM
    Mol Neurobiol; 2021 Jan; 58(1):281-303. PubMed ID: 32935230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design.
    Kumar A; Tiwari A; Sharma A
    Curr Neuropharmacol; 2018; 16(6):726-739. PubMed ID: 29542413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural products and their derivatives as multifunctional ligands against Alzheimer's disease.
    Patil P; Thakur A; Sharma A; Flora SJS
    Drug Dev Res; 2020 Apr; 81(2):165-183. PubMed ID: 31820476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer's Disease.
    Prati F; Cavalli A; Bolognesi ML
    Molecules; 2016 Apr; 21(4):466. PubMed ID: 27070562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.
    Ambure P; Bhat J; Puzyn T; Roy K
    J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer's Diseases: Emerging Paradigms and Strategies.
    Pravin N; Jozwiak K
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylcholinesterase inhibition in Alzheimer's Disease.
    Ibach B; Haen E
    Curr Pharm Des; 2004; 10(3):231-51. PubMed ID: 14754384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of oxidative stress and other pathologies in Alzheimer's disease.
    Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
    Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands.
    Iraji A; Khoshneviszadeh M; Firuzi O; Khoshneviszadeh M; Edraki N
    Bioorg Chem; 2020 Apr; 97():103649. PubMed ID: 32101780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrine-based Multifunctional Agents in Alzheimer's Disease: An Old Story in Continuous Development§.
    Milelli A; De Simone A; Ticchi N; Chen HH; Betari N; Andrisano V; Tumiatti V
    Curr Med Chem; 2017; 24(32):3522-3546. PubMed ID: 28294041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer's Disease.
    Kumar B; Thakur A; Dwivedi AR; Kumar R; Kumar V
    Curr Med Chem; 2022; 29(10):1757-1803. PubMed ID: 33982650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors.
    Roldán-Peña JM; Romero-Real V; Hicke J; Maya I; Franconetti A; Lagunes I; Padrón JM; Petralla S; Poeta E; Naldi M; Bartolini M; Monti B; Bolognesi ML; López Ó; Fernández-Bolaños JG
    Eur J Med Chem; 2019 Nov; 181():111550. PubMed ID: 31376562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer's Disease: An Update.
    de Freitas Silva M; Dias KST; Gontijo VS; Ortiz CJC; Viegas C
    Curr Med Chem; 2018; 25(29):3491-3525. PubMed ID: 29332563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.
    Loveman E; Green C; Kirby J; Takeda A; Picot J; Payne E; Clegg A
    Health Technol Assess; 2006 Jan; 10(1):iii-iv, ix-xi, 1-160. PubMed ID: 16409879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholinesterase as a Target for Drug Development in Alzheimer's Disease.
    Sharma P; Tripathi MK; Shrivastava SK
    Methods Mol Biol; 2020; 2089():257-286. PubMed ID: 31773661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease.
    Li Q; He S; Chen Y; Feng F; Qu W; Sun H
    Eur J Med Chem; 2018 Oct; 158():463-477. PubMed ID: 30243151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.